A Combined Serum Biomarker Panel for Diagnostic and Prognostic Assessment in Esophageal Squamous Cell Carcinoma.
The integrated prognostic model, combining biomarker burden with clinicopathological variables, outperformed the tumor-node-metastasis stage alone and support the use of the serum carcinoembryonic antigen, squamous cell carcinoma antigen, and carbohydrate antigen 125 panel as a practical, noninvasive adjunct for pretre...